Theravance Biopharma Overview
Theravance Biopharma Discounted Cash Flow
DCF Analysis for TBPH.
Get informed when a big investor buys or sells
+ FollowFair Value
$10.75
Current Fair Value
$10.75
↓ 34.1% Downside
Overvalued by 34.1% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison